期刊文献+

不同剂量血管加压素对脓毒症难治性休克患者血流动力学的影响 被引量:6

The Effect of the Different Dose of Teli Vasopressin in the Hemodynamics of the Patients with Septic Shock
下载PDF
导出
摘要 目的:探讨不同剂量持续输注特立加压素(TP)对脓毒症难治性休克患者心脏及血流动力学的影响。方法:选取2013年1月-2014年5月本院及佛山市第一人民医院ICU科收治的脓毒症难治性休克患者60例,按随机数字表法分为治疗组(小、大剂量组)40例及对照组20例,患者(中心静脉压≥10 cm H2O,容量负荷试验阴性)均接受适当的液体治疗和去甲肾上腺素等血管活性药物治疗,而平均动脉压低于65 mm Hg后,小、大剂量组在原有治疗基础上,分别加用不同剂量TP输注(小剂量组为0.01 U/min,大剂量组为0.04 U/min),在维持平均动脉压≥65 mm Hg的基础上调节去甲肾上腺素药物剂量。分别观察给药前,给药6、12、24、48 h后各组患者的心率(HR)、平均动脉压(MAP)、心排出量指数(CI)、外周血管阻力指数(SVRI)等血流动力学指标及去甲肾上腺素用量变化。结果:与治疗前比较,治疗后6 h,各治疗组的MAP均显著升高,HR下降,差异均有统计学意义(P<0.05);各治疗组各时点的CI、SVRI均无明显改变,与治疗前比较差异均无统计学意义(P>0.05)。大剂量组MAP、HR、维持目标MAP(10.0 kPa)所需的去甲肾上腺素用量与小剂量组比较差异均无统计学意义(P>0.05);治疗12 h后,治疗组较对照组去甲肾上腺素用量减少,差异均有统计学意义(P<0.05)。结论:持续静脉泵泵注TP能有效改善感染性休克患者的血流动力学,降低去甲肾上腺素的使用剂量,且未明显增加心脏后负荷,因而可作为一种有效的血管加压素,用于感染性休克的治疗。小剂量与较大剂量间无显著性差异。 Objective:To explore the effects of different doses of vasopressin infusion of Teli vasopressin(TP) in the heart and hemodynamics of septic shock patients.Method:From January 2013 to May 2014,the department of ICU of our hospital and Foshan first people’s hospital,60 patients of refractory septic shock were randomly divided into the treatment group(small,high-dose group)for 40 cases and the control group for 20 cases. They were treated with appropriate fluid therapy(CVP≥10 cm H2O,capacity load test was negative)and norepinephrine and other vasoactive drug therapy. When mean arterial blood pressure below 65 mm Hg,the treatment group cured with different doses Teli vasopressin infusion(low-dose group was 0.01 U/min,high-dose group was 0.04 U/min).Mean arterial pressure were maintaining ≥ 65 mm Hg basis through adjust the dose of nor-epinephrine.Before treatment and after treatment on 6,12,24,48 hours,the heart rate(HR),mean arterial pressure(MAP),cardiac output index(CI),systemic vascular resistance index(SVRI)and other blood dynamics indicators and norepinephrine dosage changes were observed.Result:Compared with before treatment,the MAP was significantly increased,the HR was declined in TP treatment group after treatment 6 hour,the differences were statistically significant(P〈0.05);the CI,SVR did not change significantly in the treatment group after treatment 6,12,24,48 hour,the differences were not statistically significant(P〉0.05). Compared with the low-dose group,MAP,HR,maintain the target MAP(10.0 kPa)required amount of norepinephrine in the high dose group,the differences were not statistically significant(P〉0.05). The amount of norepinephrine of The treatment group were reduced than the control group,the differences were statistically significant (P〈0.05). Conclusion:TP continuous intravenous infusion pump can effectively improve hemodynamics in patients with septic shock,lower doses of norepinephrine,and no significant increase in cardiac afterload,thus can be used as an effective vasopressin,for the treatment of septic shock. No significant difference between small and large dose.
出处 《中国医学创新》 CAS 2014年第21期51-53,共3页 Medical Innovation of China
关键词 感染性休克 心脏 血流动力学 特立加压素 血管加压素 Septic shock Heart Hemodynamics Teliv vasopressin Vasopressin
  • 相关文献

参考文献15

二级参考文献27

  • 1邱海波,杨毅,刘松桥.《2004严重感染和感染性休克治疗指南》系列讲座(2) 严重感染和感染性休克的容量复苏和血管活性药物应用[J].中国危重病急救医学,2004,16(8):451-453. 被引量:111
  • 2Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ ATS/SIS International sepsis Definitions Conference Crit Care Med, 2003, 31(4): 1250-1256.
  • 3Nguyen HB, Rivers EP, Knoblich BP, et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med, 2004, 32(8): 1637-1642.
  • 4Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States:analysis of incidence, outcome, and associated costs of care. Crit Care Med, 2001, 29(7): 1303-1310.
  • 5Martin C, Viviand X, Leone M, et al. Effect of norepinephfine on the outcome of septic shock. Crit Care Med, 2000, 28(8): 2758-2765.
  • 6McNelis J, Marini CP, Jurkiewicz A, et al. Prolonged lactate clearance is associated with increased mortality in the surgical intensive care unit. Am J Surg, 2001, 182(5): 481-485.
  • 7Reinhart K, Kuhn H J, Hartog C, et al. Continuous central venous and pulmonary artery oxygen saturation monitoring in the critically ill. Intensive Care Med, 2004, 30(8): 1572-1578.
  • 8Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med, 2001, 345 (19): 1368-1377.
  • 9Vincent JL Biston P, Devriendt J, et al. Dopamine versus norepinephrine:is one better? Minerva Anestesiol, 2009, 75(5): 333-337.
  • 10De Backer D, Creteur J, Silva E, et al. Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best? Crit Care Med, 2003, 31 (6): 1659-1667.

共引文献137

同被引文献72

  • 1欧江荣,刘坤,谭兰.他汀类药物对脑梗死病人血清中TNF-α及IL-6的影响[J].中国新药与临床杂志,2007,26(7):552-555. 被引量:11
  • 2Batzofint B M, Sprung C L, Weiss Y G.The use of steroids in the treatment of severe sepsis and septic shock[J].Best Pract Res Clin Endocrinol Metab, 2011, 25 ( 5 ) : 735-743.
  • 3Lira S Y, Jeon E J, Kim H J, et al.The incidence, causes, and prognostic significance of new-onset thrombocytopenia in intensive care units: a prospective cohort study in a Korean hospital[J].Korean Med Sei, 2012, 27 ( 11 ) : 1418-1423,.
  • 4Dellinqer R P, Levy M M, Carlet J M, et al.Surving sepsis campaign: international guidelines for managerment of severe sepsis and septic shock 2008[J].Crit Care Med, 2008, 36 ( 1 ) : 296-327.
  • 5Zanotti-Cavazzoni S L,Hollenberg S M.Cardiac dysfunction in severe sepsis and septic shock[J].Curr Opin Crit Care,2009,15(5):392-397.
  • 6Werdan K,Oelke A,Hettwer S,et al.Septic cardiomyopathy:hemodynamic quantification,occurrence and prognostic implications[J].Clin Res Cardiol,2011,100(8):661-668.
  • 7Ohsawa L,Ishikawa M.Takahaski K,et al.Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals[J].Nat Med,2007,13(6):688-693.
  • 8Aird W C.The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome[J].Blood,2003,101(10):3765-3777.
  • 9Xie K L,Yu Y H,Zhang Z S,et al.Hydrogen gas improves survival rate and organ damage in zymosan-induced generalized inflammation model[J].Shock,2010,34(5):495-501.
  • 10Rezkalla S,Kloner R A,Khatib G,et al.Effect of metoprolol in acute coxsackievirus B3 murine myocarditis[J].J Am Coll Cardiol,1988,12(2):412-414.

引证文献6

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部